Leigong Tengduo Gan Pian (雷公藤多苷片)雷公藤多苷片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 浙江得恩德制药有限公司Chinese legal name: 浙江得恩德制药有限公司
主要成分Active Ingredients
- 雷公藤多苷Leigong Tengduo Gan
- 主要成份是雷公藤多苷Recorded Chinese composition: 主要成份是雷公藤多苷
药物知识说明
雷公藤多苷是一种在国家药监局注册认定的药品。该药品含有主要成份是雷公藤多苷、雷公藤多苷-6833964c等成分。
该药品关联的活性成分包括：主要成份是雷公藤多苷Recorded Chinese composition: 主要成份是雷公藤多苷、雷公藤多苷Leigong Tengduo Gan。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：浙江得恩德制药有限公司Chinese legal name: 浙江得恩德制药有限公司。
您可以探索含有相同成分的其他药品：主要成份是雷公藤多苷-ac39423f成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 雷公藤多苷片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 主要成份是雷公藤多苷Recorded Chinese composition: Recorded Chinese name: 主要成份是雷公藤多苷, 雷公藤多苷Leigong Tengduo Gan.
Manufacturers recorded for this product: 浙江得恩德制药有限公司Chinese legal name: 浙江得恩德制药有限公司.
Explore other medicines containing the same ingredient: products containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 雷公藤多苷片Recorded Chinese name: 雷公藤多苷片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 10毫克×50片。10 mg × 50 tablets
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 浙江得恩德制药有限公司Chinese legal name: 浙江得恩德制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字Z33020422
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字Z33020422
Manufacturer
Chinese legal name: 浙江得恩德制药有限公司 (domestically manufactured)
Traditional functions
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字Z33020422
生产企业
浙江得恩德制药有限公司(国产)
功能主治
祛风解毒，除湿消肿，舒筋通络，有抗炎及抑制细胞免疫和体液免疫等作用，本品主要用于风湿热瘀，毒邪阻滞所致的类风湿性关节炎，肾病综合症，白塞氏三联症，麻风反应，自身免疫性肝炎等。
用法用量
口服,按体重每1kg每日1-1..mg,分3次饭后服用,或遵医嘱。
不良反应
服药期间可引起月经紊乱,精子活力及数目减少,白细胞和血小板减少,停药后可恢复。
禁忌
孕妇禁用。
注意事项
1.老年有严重心血管病者慎用。
2.偶有胃肠道反应，可耐受。
3.罕见：有血小板减少，且程度较轻，一般无需停药。
4.可致月经紊乱及精子活力降低，数量减少，上述不良反应停药可恢复正常。
贮藏
密封，遮光，置干燥处。
规格
10毫克×50片。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.